My expectation of the upcoming timeline,
1. fda advises no change following type A meeting
2. Mid December Overwhelming efficacy following next interim analysis and gains approval for use from fda.
3. Msb request second type A meeting for GVHD with entirely new staff from the fda who say “silviu, broooo, so so sorry for how shit my colleagues are at doing there job, I hired them from Craigslist, this should have been approved 2 months ago, but yeah bro no dramas, consider it approved now that you also have approval for ARDS, anyway I gotta go man, got some people to sack, see you at the next one legend (chf and back pain)
4.back pain and chf results come out (hopefully positive)
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-515
-
- There are more pages in this discussion • 297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 99.5¢ | 96.0¢ | $2.283M | 2.340M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29300 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |